Inhibikase Therapeutics(IKT) - 2023 Q1 - Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2023 Earnings Conference Call May 16, 2023 8:00 AM ET Company Participants Alex Lobo - Stern IR Milton Werner - President & CEO Joseph Frattaroli - CFO Conference Call Participants Edward White - H.C. Wainwright Operator Good morning and welcome to the Inhibikase Therapeutics First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask q ...